Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Health Services Research
Published in: BMC Health Services Research 1/2008

Open Access 01-12-2008 | Research article

Comparative indicators for cancer network management in England: Availability, characteristics and presentation

Authors: Mark McCarthy, Arturo Gonzalez-Izquierdo, Chris Sherlaw-Johnson, Artak Khachatryan, Michel P Coleman, Bernard Rachet

Published in: BMC Health Services Research | Issue 1/2008

Login to get access

Abstract

Background

In 2000, the national cancer plan for England created 34 cancer networks, new organisational structures to coordinate services across populations varying between a half and three million people. We investigated the availability of data sets reflecting measures of structure, process and outcome that could be used to support network management.

Methods

We investigated the properties of national data sets relating to four common cancers – breast, colorectal, lung and prostate. We reviewed the availability and completeness of these data sets, identified leading items within each set and put them into tables of the 34 cancer networks. We also investigated methods of presentation.

Results

Acute Hospitals Portfolio and the National Cancer Peer Review recorded structural characteristics at hospital and cancer service level. Process measures included Hospital Episode Statistics, recording admissions, and Cancer Waiting List data. Patient outcome measures included the National Survey: Cancer Patients, and Cancer Survival, drawn from cancer registration.

Conclusion

While not as yet used together in practice, comparative indicators are available within the National Health Service in England for use in performance assessment by cancer networks.
Appendix
Available only for authorised users
Literature
1.
Department of Health: The NHS cancer plan and the new NHS: Providing a patient-centred service. 2004, London, UK Department of Health
2.
Calman K, Hine D: A Framework for Commissioning Cancer Services. 1995, London, Department of Health
3.
Department of Health: A Cancer Plan for England. 2000, London, Department of Health
4.
Department of Health: NHS Cancer Information Strategy. 2000, Department of Health, (Gateway no 2000)
5.
6.
Donabedian A: The quality of care. How can it be assessed?. JAMA. 1988, 260 (12): 1743-1748. 10.1001/jama.260.12.1743.CrossRefPubMed
7.
Mainz J: Defining and classifying clinical indicators for quality improvement. International Journal for Quality in Health Care. 2003, 15 (6): 523-530. 10.1093/intqhc/mzg081.CrossRefPubMed
8.
Audit Commission: NHS Cancer Care in England and Wales (National Service Framework Assessments No. 1). 2002, London, Audit Commission
9.
Black N, Payne M: Directory of clinical databases: improving and promoting their use. Quality and Safety in Health Care. 2003, 12 (5): 348-52. 10.1136/qhc.12.5.348.CrossRefPubMedPubMedCentral
10.
11.
12.
Rachet B, Coleman MP: Cancer survival indicators for the National Health Service in England: exploration of alternative geographic units of analysis. Primary Care Organisation and the Strategic Health Authority: Report for the National Centre for Outcomes Development. 2004, Department of Health, London
13.
Prescott A, (for National Centre for Social Research): National survey of NHS patients. Cancer: analysis of themes. 2004, London, Department of Health
14.
15.
Lilford R, Mohammed MA, Spiegelhalter D, Thomson R: Use and misuse of process and outcome data in managing performance of acute medical care: avoiding institutional stigma. Lancet. 2004, 363: 1147-54. 10.1016/S0140-6736(04)15901-1.CrossRefPubMed
16.
Lakhani P, Coles J, Eyres D, Spence P, Rachet B: Creative use of existing clinical and health outcomes data to assess NHS performance in England: Part 1 – performance indicators closely linked to clinical care. BMJ. 2005, 330 (7505): 1426-31. 10.1136/bmj.330.7505.1426.CrossRefPubMedPubMedCentral
17.
18.
Flowers J, Hall P, Pencheon D: Public health indicators. Public Health. 2005, 119 (4): 239-45. 10.1016/j.puhe.2005.01.003.CrossRefPubMed
19.
Bird SM, Cox D, Farewell VT, Goldstein H, Holt T, Smith PC: Performance indicators: good, bad and ugly. J R Stat Soc A. 2005, 168 (1): 1-28. 10.1111/j.1467-985X.2004.00333.x.CrossRef
20.
Spiegelhalter DJ: Problems in assessing rates of infection with methicillin resistant Staphylococcus aureus. BMJ. 2005, 331 (7523): 1013-5. 10.1136/bmj.331.7523.1013.CrossRefPubMedPubMedCentral
21.
Freeman T: Using performance indicators to improve health care quality in the public sector: a review of the literature. Health Serv Manage Res. 2002, 15 (2): 126-37. 10.1258/0951484021912897.CrossRefPubMed
22.
Williams SC, Schmaltz SP, Morton DJ, Koss RG, Loeb JM: Quality of Care in U.S. Hospitals as reflected by standardized measures, 2002–2004. N Engl J Med. 2005, 353 (3): 255-264. 10.1056/NEJMsa043778.CrossRefPubMed
23.
24.
Addicott R, McGivern G, Ferlie E: Networks, Organizational Learning and Knowledge Management: NHS Cancer Networks. Public Money & Management. 2006, 26 (2): 87-94. 10.1111/j.1467-9302.2006.00506.x.CrossRef
25.
Richardson A, Sitzia J, Cottrell P: 'Working the system'. Achieving change through partnership working: an evaluation of partnership programmes. Health Expectations. 2005, 8: 210-20. 10.1111/j.1369-7625.2005.00332.x.CrossRefPubMed
26.
National Audit Office: The 1992 and 1998 IM&T strategies of the NHS Executive. 1999, London, Stationery Office, (HC371, 1998–99)
27.
Clauser SB: Use of cancer performance measures in population health: a macro-level perspective. Journal of the National Cancer Institute Monographs. 2004, (33): 142-54. 10.1093/jncimonographs/lgh020.
28.
Berrino F, Sant M, Verdecchia R, Capocaccia R, Hakulinen T, Esteve J, (eds): Survival of cancer patients in Europe: the Eurocare Study. 1995, Lyon: International Agency for Research on Cancer
29.
Metadata
Title
Comparative indicators for cancer network management in England: Availability, characteristics and presentation
Authors
Mark McCarthy
Arturo Gonzalez-Izquierdo
Chris Sherlaw-Johnson
Artak Khachatryan
Michel P Coleman
Bernard Rachet
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2008
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/1472-6963-8-45

Other articles of this Issue 1/2008

BMC Health Services Research 1/2008 Go to the issue

Research article

Effects of intensive home visiting programs for older people with poor health status: A systematic review

Research article

Availability of supplies and motivations for accessing voluntary HIV counseling and testing services in Blantyre, Malawi

Research article

Interventions designed to improve the quality and efficiency of medication use in managed care: A critical review of the literature – 2001–2007

Technical advance

Supported housing programs for persons with serious mental illness in rural northern communities: A mixed method evaluation

Research article

Estimated time spent on preventive services by primary care physicians

Research article

Cancer surviving patients' rehabilitation – understanding failure through application of theoretical perspectives from Habermas